The statute uses the terms “drug abuser or addict,” but current immigration medical practice uses the DSM diagnosis of a substance use disorder. A drug arrest, lawful marijuana use under state law, experimentation, prior treatment, a prescription, or one positive toxicology result does not automatically establish Class A medical inadmissibility. The civil surgeon or panel physician must identify a current substance use disorder involving a substance controlled under federal law, document at least two DSM criteria, and determine whether sustained remission has been established. Because there is generally no ordinary immigrant waiver for a current controlled-substance use disorder, accurate diagnosis, testing, treatment, abstinence, documentation, and reexamination are critical.
Nationwide and international immigration representation through Messersmith Law Firm, P.A.
INA §212(a)(1)(A)(iv) makes inadmissible a person determined, under regulations prescribed by the Secretary of Health and Human Services, to be a drug abuser or addict. Current CDC Technical Instructions implement this language through the DSM-5-TR diagnosis of a substance use disorder involving a substance listed in Schedules I through V of the federal Controlled Substances Act.
The medical ground concerns a current diagnosable disorder. It does not require a criminal conviction, a legally valid admission to a crime, associated harmful behavior, or a particular severity level once the DSM diagnosis involving a federally controlled substance is established.
The substance category changes both the Class A test and waiver availability.
A current DSM substance use disorder involving any substance in federal Schedules I through V is Class A. Additional harmful behavior is not required. Ordinary immigrant waiver relief is generally unavailable.
Alcohol and other psychoactive substances not federally scheduled are evaluated under the separate physical or mental disorder with associated harmful behavior ground. A disorder without qualifying harmful behavior is generally Class B.
A substance use disorder is a pattern of continued use despite significant substance-related problems. Current CDC instructions require the physician to assess all eleven DSM criteria and identify at least two occurring within the diagnostic period.
The criteria are grouped into impaired control, social impairment, risky use, and pharmacologic features. The physician must document the specific criteria rather than simply writing “drug abuse,” “addiction,” “history of marijuana,” or “positive test.”
Using more or longer than intended, unsuccessful attempts to reduce use, substantial time obtaining or recovering from the substance, or craving.
Repeated failure in work, school, family, or other major roles; continued use despite interpersonal problems; or abandonment of important activities.
Recurrent use in physically hazardous situations or continued use despite knowledge of a physical or psychological problem caused or worsened by the substance.
Tolerance or withdrawal, subject to DSM exceptions for medication taken solely under appropriate medical supervision.
Current CDC instructions require the civil surgeon or evaluating specialist to clearly document the specific DSM criteria supporting the substance use disorder. A conclusion without the diagnostic foundation can support correction, reexamination, or an RFE response.
The applicant currently meets at least two DSM criteria for a substance use disorder involving a federally controlled substance and has not established remission.
The applicant had a controlled-substance use disorder but has met the current sustained-remission requirements.
The applicant has no diagnosable disorder or used a substance occasionally but does not meet at least two DSM criteria.
Marijuana and federally controlled THC remain Controlled Substances Act substances for immigration medical analysis despite legalization or decriminalization by some states or foreign countries. Medical authorization under state law does not by itself remove the federal immigration concern.
Current CDC instructions also make clear that occasional marijuana use or one positive urine test does not automatically create Class A inadmissibility. The applicant must meet at least two DSM criteria for a cannabis or other substance use disorder.
Controlled medication taken in accordance with a valid prescription for legitimate clinical care does not by itself amount to a substance use disorder. The physician should review the prescription, prescriber, dosage, pharmacy history, diagnosis, duration, adherence, and functional effect.
Misuse can require a full substance-use-disorder assessment. Warning signs can include taking another person’s medicine, obtaining multiple overlapping prescriptions, escalating the dose without direction, crushing or injecting medication, repeated early refills, or continued nonmedical use despite significant problems.
Substance, route, amount, frequency, age at first use, last use, prescriptions, intoxication, withdrawal, treatment, relapse, and recovery history.
The physician evaluates each of the eleven criteria and records which criteria are met or were met historically.
Police, court, probation, military, school, employment, hospital, rehabilitation, prescription, family, and prior immigration records may be reviewed.
Testing is ordered when the individual history, examination, contradictions, positive screen, suspected disorder, deferral, or remission assessment justifies it.
An addiction psychiatrist, psychiatrist, psychologist, addiction-medicine physician, or other qualified specialist may evaluate diagnosis and remission.
The designated physician completes the immigration report and attaches the original English-language specialist and laboratory records.
Current CDC instructions prohibit routine population-wide drug testing. The civil surgeon should decide whether testing is medically indicated based on the individual history, presentation, physical findings, records, reliability, suspected diagnosis, prior positive result, deferral, or remission claim.
Screening tests must use appropriate FDA-licensed materials. A positive screening result should be confirmed through the required reference-laboratory method rather than treated as conclusive without confirmation.
When the evidence is insufficient to determine whether a controlled-substance use disorder exists, current CDC instructions permit the civil surgeon to defer diagnosis or classification for three to six months.
During that period, the applicant must complete at least three random controlled- substance laboratory screenings on short notice—generally within twenty-four to forty-eight hours after notification—along with any treatment, records, specialist evaluation, or monitoring required by the physician.
The ordinary way to overcome current Class A controlled-substance use disorder is to establish sustained remission and obtain a new official medical classification. Current CDC instructions require at least twelve consecutive months during which the applicant meets no DSM criterion except craving, together with full abstinence from the controlled substance.
Abstinence must be verified through at least four random short-notice laboratory screenings over the twelve-month period. Treatment, recovery programs, family observations, rehabilitation records, medical follow-up, and stable functioning should corroborate the testing.
Date-specific results, short-notice documentation, substances tested, confirmation, laboratory credentials, and specimen integrity.
Inpatient or outpatient rehabilitation, medication-assisted treatment, counseling, psychiatry, support groups, relapse-prevention, and discharge records.
A specialist opinion explaining why no current DSM criterion is met, other than craving where applicable.
Employment, education, family care, housing, finances, health, compliance, and ordinary daily responsibilities.
Family, therapist, sponsor, physician, employer, community, and recovery-program statements based on personal knowledge.
Police clearance, court compliance, prescription monitoring, treatment adherence, and absence of later drug-related events.
INA §212(g) provides waivers for certain communicable diseases, vaccination issues, and disorders with associated harmful behavior, but it does not create an ordinary waiver for current drug abuse or addiction under INA §212(a)(1)(A)(iv).
A family relationship, extreme hardship, approved I-130 or I-140, long residence, rehabilitation, or absence of a conviction does not substitute for sustained remission. The applicant ordinarily must complete the current CDC remission requirements and receive a new Class B or no-Class-A classification.
The ordinary no-waiver rule should not be applied without reviewing the actual immigration classification.
INA §212(d)(3)(A) may permit temporary travel after discretionary review of the medical condition, treatment, public-safety risk, travel purpose, and compliance.
T and U statutes provide broad waiver authority, subject to classification- specific standards, exclusions, public or national interest, and discretion.
INA §209(c) contains separate humanitarian, family-unity, and public-interest waiver authority, subject to the grounds Congress excluded.
SIJ, VAWA, legalization, registry, and other statutes may have specialized admissibility rules. Current medical remission may remain practically important even where broader legal relief exists.
A Class A controlled-substance use disorder does not necessarily foreclose every temporary visit. A discretionary nonimmigrant waiver may be available when the applicant otherwise qualifies for the visa and presents a credible, limited, and adequately controlled travel plan.
The adjudication may consider the seriousness and recency of use, diagnosis, treatment, toxicology, risk of possession or use in the United States, criminal history, purpose and duration of travel, medical supervision, foreign ties, and every additional inadmissibility ground.
A current DSM controlled-substance use disorder can create inadmissibility without a conviction or valid criminal admission.
A conviction or legally valid admission to conduct violating a law relating to a federally controlled substance can create separate criminal inadmissibility.
Government knowledge or reason to believe that the person knowingly assisted, conspired in, or participated in illicit trafficking can create a ground without conviction.
False answers about use, treatment, arrests, prescriptions, testing, or medical history can create permanent fraud inadmissibility when the legal elements are met.
INA §237(a)(2)(B)(ii) separately makes a person who is, or after admission has been, a drug abuser or addict deportable.
INA §212(h) has a narrow waiver for one qualifying offense of simple possession of thirty grams or less of marijuana. It does not waive a current medical disorder.
USCIS distinguishes medical evidence of use from the technical requirements for a valid criminal admission. Nevertheless, the medical report, applicant statements, police records, and other evidence can lead to separate criminal or trafficking review. Every answer must be truthful and carefully analyzed.
The report identifies use, possession, arrest, or a positive test but does not establish a diagnosable substance use disorder.
Properly supervised clinical use is treated as nonmedical misuse without reviewing the prescription, diagnosis, dosage, or treatment plan.
A screening result is treated as final despite no confirmatory test, cross-reactivity, specimen issue, prescription explanation, or chain-of-custody problem.
Old experimentation or treatment is labeled current without assessing the present DSM criteria and sustained remission.
Twelve months of abstinence, random testing, treatment, stable functioning, and corroboration are omitted or incorrectly evaluated.
The product, laboratory analyte, prescription, metabolite, or federal controlled-substance status is not identified accurately.
State legality is relied upon without addressing federal controlled-substance law, the medical ground, criminal admissions, or marijuana-industry activity.
Discontinuing counseling or medication without medical direction can undermine recovery, credibility, safety, and remission evidence.
Predictable monthly testing may not satisfy the CDC short-notice requirement for deferral or sustained remission.
Unsupported claims of past abstinence can cause the physician to begin the remission period only after the first properly documented negative random test.
Form I-601 is submitted without a statutory basis instead of completing remission and obtaining a new medical classification.
Denials contradicted by tests, prescriptions, police reports, social media, or prior applications can create credibility and fraud problems beyond the medical ground.
Review all four medical inadmissibility categories and available remedies.
Review the health-related hub →Review tuberculosis, syphilis, gonorrhea, Hansen disease, treatment, and waivers.
Review communicable diseases →Review records, blanket waivers, and religious or moral-conviction relief.
Review vaccination rules →Review alcohol-related harmful behavior, remission, Class A findings, and waivers.
Review harmful behavior →Review correction, treatment, reclassification, and category-specific waiver strategy.
Review Class A conditions →Review I-693 errors, civil-surgeon disputes, RFEs, medical holds, and reexamination.
Review medical-exam problems →Messersmith Law Firm, P.A. represents adjustment and immigrant-visa applicants facing Class A controlled-substance use disorder findings, marijuana-related medical issues, positive toxicology, prescription-drug allegations, deferred classifications, remission disputes, RFEs, medical holds, and overlapping criminal controlled-substance grounds.
These matters often require coordination with civil surgeons, panel physicians, addiction psychiatrists, addiction-medicine physicians, rehabilitation programs, toxicology laboratories, treating providers, USCIS, CDC, and consular officers.
The strongest strategy may be to prove that fewer than two DSM criteria exist, explain a prescription or unreliable test, distinguish occasional use from a disorder, begin a compliant random-testing program, document twelve months of sustained remission, obtain a new medical classification, or pursue an available temporary or classification-specific waiver.
The correct result depends on the substance, federal schedule, DSM criteria, prescriptions, testing, examination date, treatment, remission, official medical classification, immigration category, and separate criminal or trafficking grounds.
No. Current CDC instructions require a diagnosable substance use disorder involving a federally controlled substance. The civil surgeon must evaluate all 11 DSM criteria, and at least two criteria must be met. Occasional use or one positive drug test alone does not establish Class A inadmissibility.
It can. Marijuana containing federally controlled THC remains a Controlled Substances Act substance despite legalization under some state or foreign laws. A medical Class A finding still requires at least two DSM substance-use-disorder criteria; occasional use or one positive test is not enough. Criminal and trafficking grounds require separate analysis.
No. A current substance use disorder of any severity involving a substance listed in Schedules I through V of the Controlled Substances Act is Class A without proof of additional harmful behavior.
No. A positive screen is evidence requiring evaluation and confirmation, not the diagnosis itself. The physician must assess the DSM criteria, substance history, prescriptions, records, reliability of the test, and any confirmatory testing.
Medication taken properly under a valid prescription does not by itself amount to a substance use disorder. Misuse, nonmedical use, doctor shopping, taking another person's prescription, escalating doses, or continued use despite substantial problems can support further evaluation.
Current CDC instructions require at least 12 consecutive months during which the applicant meets no DSM substance-use-disorder criterion other than craving, plus complete abstinence from the controlled substance.
For sustained remission from a controlled-substance use disorder, CDC requires at least four random laboratory screenings on short notice over a 12-month period. If a diagnosis or classification is deferred for three to six months, at least three random short-notice tests are required during the deferral.
There is generally no ordinary immigrant or adjustment waiver for a current Class A controlled-substance use disorder. The applicant ordinarily must establish sustained remission and obtain a new Class B or no-Class-A medical classification.
Potentially. INA Section 212(d)(3)(A) may permit a discretionary temporary nonimmigrant waiver. The applicant must still qualify for the visa and address the current medical condition, treatment, risk, travel purpose, compliance, and any separate criminal or trafficking grounds.
Yes. The medical ground under INA Section 212(a)(1)(A)(iv) can apply without a conviction if the physician diagnoses a current controlled-substance use disorder. A conviction or legally valid admission to a controlled-substance offense is analyzed separately under INA Section 212(a)(2), and suspected trafficking can create another ground.
Identify the substance and federal status, require a criterion-by-criterion DSM analysis, verify toxicology and prescriptions, distinguish occasional use from a current disorder, begin compliant short-notice testing, document sustained remission, obtain the correct official classification, and analyze every separate criminal, trafficking, fraud, and waiver issue before filing.
This page provides general information and does not create an attorney-client relationship or constitute legal or medical advice. Immigration consequences depend on the specific substance, diagnosis, testing, treatment, medical classification, criminal record, immigration category, agency, and controlling law.
